What are Beta Bionics, Inc. Common Stock's total assets?

Beta Bionics, Inc. Common Stock (BBNX) holds $304.4M in total assets, down 9.9% year over year.

How much debt does Beta Bionics, Inc. Common Stock have?

Beta Bionics, Inc. Common Stock carries $6.9M in total debt against $271.2M of shareholders' equity, a debt-to-equity ratio of 0.03.

How much cash does Beta Bionics, Inc. Common Stock have?

Beta Bionics, Inc. Common Stock holds $30.2M in cash and equivalents.

Can Beta Bionics, Inc. Common Stock cover its short-term obligations?

Its current ratio is 10.69 — current assets exceed current liabilities.

Where does Beta Bionics, Inc. Common Stock's balance sheet data come from?

Every line is extracted from Beta Bionics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Beta Bionics, Inc. Common Stock BBNX Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$30.21M-4.3%	$31.58M-18.0%	$38.49M+9.7%	$35.08M-17.4%	$42.45M+39.5%
Short-term investments	$169.31M-9.7%	$187.55M-1.4%	$190.2M—	——	——
Restricted cash	$100K0.0%	$100K0.0%	$100K—	——	——
Accounts receivable, net	$55.8M+13.6%	$49.11M+11.6%	$43.99M—	——	——
Inventories	$83.15M+10.6%	$75.15M+12.6%	$66.75M+32.7%	$50.3M+36.4%	$36.87M+56.6%
Prepaid expenses and other current assets	$35.79M+9.9%	$32.56M+21.7%	$26.75M+47.7%	$18.11M+73.0%	$10.47M+78.1%
Total current assets	$247.99M-7.4%	$267.91M-0.8%	$270.03M—	——	——
Property and equipment, net	$10.16M+18.1%	$8.6M+16.5%	$7.39M—	——	——
Operating lease right-of-use assets	$6.23M-6.1%	$6.63M-5.7%	$7.02M—	——	——
Other non-current assets	$181K+0.6%	$180K-1.6%	$183K—	——	——
Equity method investments	$39.87M-12.3%	$45.43M—	——	——	——
Total assets	$304.42M-7.4%	$328.74M-0.4%	$330.05M—	——	——
Accounts payable	$15.2M-7.0%	$16.34M+15.1%	$14.19M+44.3%	$9.84M+31.6%	$7.47M+68.7%
Accrued expenses	$17.33M-22.7%	$22.43M+27.4%	$17.61M—	——	——
Deferred revenue	$3.35M+1.6%	$3.3M+10.4%	$2.99M—	——	——
Operating lease liabilities, current	$1.84M-5.1%	$1.94M-2.1%	$1.98M—	——	——
Total current liabilities	$23.19M-25.0%	$30.92M+21.8%	$25.39M—	——	——
Operating lease liabilities, non-current	$5.07M-5.4%	$5.37M-6.0%	$5.71M—	——	——
Operating Lease Liabilities (Total)	$6.91M-5.4%	$7.3M-5.0%	$7.69M—	——	——
Other non-current liabilities	$1.56M—	——	——	——	——
Total liabilities	$33.17M-19.4%	$41.13M+16.6%	$35.29M—	——	——
Common stock	$5K+25.0%	$4K0.0%	$4K—	——	——
Additional paid-in capital	$663.17M+0.9%	$657.14M+1.0%	$650.87M—	——	——
Retained earnings	-$391.83M-5.9%	-$369.94M-3.8%	-$356.47M—	——	——
Accumulated other comprehensive income (loss)	-$96K-124%	$403K+13.8%	$354K—	——	——
Total stockholders' equity	$271.25M-5.7%	$287.61M-2.4%	$294.76M-2.3%	$301.63M-3.9%	$313.75M+228%
Total liabilities and stockholders' equity	$304.42M-7.4%	$328.74M-0.4%	$330.05M—	——	——
Deferred Tax Assets and Other Non-Current Assets	$181K+0.6%	$180K-1.6%	$183K—	——	——
Net Investment in Lease	$6.23M-6.1%	$6.63M-5.7%	$7.02M—	——	——
Investments	$39.87M-12.3%	$45.43M—	——	——	——
Operating lease right-of-use assets	$6.23M-6.1%	$6.63M-5.7%	$7.02M—	——	——
Other non-current assets	$181K+0.6%	$180K-1.6%	$183K—	——	——
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)	$169.31M-9.7%	$187.55M-1.4%	$190.2M—	——	——
Operating Lease Right-of-Use Assets in Other Assets	$6.23M-6.1%	$6.63M-5.7%	$7.02M—	——	——
Software and Technology Licenses, Net	$181K+0.6%	$180K-1.6%	$183K—	——	——
Deferred income	$1.71M+9.5%	$1.56M+16.0%	$1.34M—	——	——
Accrued expenses and other liabilities	$17.33M-22.7%	$22.43M+27.4%	$17.61M—	——	——
Deferred income	$3.35M+1.6%	$3.3M+10.4%	$2.99M—	——	——
Total debt	$6.91M-5.4%	$7.3M-5.0%	$7.69M—	——	——
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$5K+25.0%	$4K0.0%	$4K—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Beta Bionics, Inc. Common Stock.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Beta Bionics, Inc. Common Stock's total assets?: Beta Bionics, Inc. Common Stock (BBNX) holds $304.4M in total assets, down 9.9% year over year.
How much debt does Beta Bionics, Inc. Common Stock have?: Beta Bionics, Inc. Common Stock carries $6.9M in total debt against $271.2M of shareholders' equity, a debt-to-equity ratio of 0.03.
How much cash does Beta Bionics, Inc. Common Stock have?: Beta Bionics, Inc. Common Stock holds $30.2M in cash and equivalents.
Can Beta Bionics, Inc. Common Stock cover its short-term obligations?: Its current ratio is 10.69 — current assets exceed current liabilities.
Where does Beta Bionics, Inc. Common Stock's balance sheet data come from?: Every line is extracted from Beta Bionics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.